Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Michael Waters, MD

Velocity Clinical Research

Disclosure(s): No financial relationships to disclose

Poster(s):

(P-1090) Rifaquizinone for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Multicenter, Double-Blind, Randomized, Active-Controlled, Phase 2 Trial

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT